Hangzhou Tengdi Biomedical Technology
Latest round
- Seed
Last raised
- Dec 2021
Total raised
- $3.3M
Investors
- 1
About Hangzhou Tengdi Biomedical Technology
Established in 2021 and based in Hangzhou, China, Hangzhou Tengdi Biomedical Technology is a biopharmaceutical company that focuses on AI-assisted design of new protein drug research and development. The company founder and CEO Dr. Mingfu Zhu is the assistant professor of bioinformatics at Duke University School of Medicine. The company's main business is AI-assisted research, development and design of new protein drug.
Who invested in Hangzhou Tengdi Biomedical Technology
1 investor across 1 round
See all investors in Hangzhou Tengdi Biomedical Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 17, 2021
Amount
$3.3M
Investors
Questions about Hangzhou Tengdi Biomedical Technology
Who invested in Hangzhou Tengdi Biomedical Technology?
Hangzhou Tengdi Biomedical Technology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Tengdi Biomedical Technology raised?
Hangzhou Tengdi Biomedical Technology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hangzhou Tengdi Biomedical Technology last raise money?
Hangzhou Tengdi Biomedical Technology's most recent round on record is a Seed, in Dec 2021.
What does Hangzhou Tengdi Biomedical Technology do?
Established in 2021 and based in Hangzhou, China, Hangzhou Tengdi Biomedical Technology is a biopharmaceutical company that focuses on AI-assisted design of new protein drug research and development.
Where is Hangzhou Tengdi Biomedical Technology headquartered?
Hangzhou Tengdi Biomedical Technology is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Tengdi Biomedical Technology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Hangzhou Tengdi Biomedical Technology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Hangzhou Tengdi Biomedical Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.